All in our genes? From foetal nonsense to adult neoplasia

Size: px
Start display at page:

Download "All in our genes? From foetal nonsense to adult neoplasia"

Transcription

1 All in our genes? From foetal nonsense to adult neoplasia Raoul CM Hennekam Department of Pediatrics, AMC, Amsterdam

2 Robert J Gorlin

3 minor anomaly > malformation

4 minor anomaly > malformation

5 minor anomaly > malformation

6 minor anomaly > malformation Major malformations in children with mild errors of morphogenesis or more Marden, 1964 Mehes, 1983 Merlob, 1985 Leppig, 1987

7 malformation > cancer Malformations and cancer Down syndrome

8 malformation > cancer Malformations and cancer Beckwith-Wiedemann syndrome

9 malformation < > cancer Principle Ponder, Nature 2001;411:336

10 malformation < > cancer Principle Villavicencio, Am J Hum Genet 2000;67:1047

11 malformation < > cancer Holoprosencephaly

12 malformation < > cancer Holoprosencephaly

13 malformation < > cancer Holoprosencephaly Amsterdam / Enschede study - all holoprosencephaly patients n = lobar, 15 alobar, 2 lobar, 2? - 15 isolated, 26 syndromic - 4 survivors (4y,14y, 26y, 30y) - no consanguinity - parental age: somewhat increased - recurrence: 1 family - family: 7 times NTD 4 times brain tumor Van Eeghen et al, unpublished

14 freq cancer in malformation Frequency Malformation: chance cancer? - depending entity - depending cause - depending knowledge

15 freq cancer in malformation Malformation syndrome and cancer Gorlin syndrome

16 freq cancer in malformation Malformation syndrome and cancer Gorlin syndrome

17 freq cancer in malformation Malformation syndrome and cancer Gorlin syndrome

18 freq cancer in malformation Malformation syndrome and cancer Gorlin syndrome

19 freq cancer in malformation Malformation syndrome and cancer Gorlin syndrome

20 freq cancer in malformation Malformation syndrome and cancer 20% develops cancer <40yr Rubinstein-Taybi syndrome

21 freq cancer in malformation Beckwith-Wiedemann s

22 freq cancer in malformation Beckwith-Wiedemann s (n=1,923) tumour/total tumour % Wilms Hepatoblastoma Other IC2 26/ % +/- +/- +/- IC1 41/ % UPD 59/ % CDKN1C 5/72 8.0% no defect 23/ % Total 155/ % Maas S, Am J Med Genet 2016 [Epub ahead of print]

23 freq cancer in malformation Beckwith-Wiedemann s Maas S, Am J Med Genet 2016 [Epub ahead of print]

24 freq cancer in malformation Malformation syndrome and cancer Cordeddu, Nat Genet 2014;46:815 one patient twice testis carcinoma 27y / 39y n = 8 Primrose syndrome

25 freq malformation in cancer Frequency Cancer: chance malformation? - 1,073 consecutive children with cancer all dysmorphisms - single investigator - 7% scored independently 2nd investigator - kappa analyses; syndromes? Merks J, Am J Med Genet 2005;134A:132

26 freq malformation in cancer Frequency Tumor Groups Neuroblastoma Rhabdomyosarcoma Germ cell tumors Nephroblastoma Osteosarcoma Ewing sarcoma Medulloblastoma Non-Hodgkin Lymphoma Hodgkin Disease ALL n

27 freq malformation in cancer Frequency Neuroblastoma (n=66) Acute Lymphoblastic Leukemia (n=190) Hodgkin's disease (n=87) Non-Hodgkin's Lymphoma (n=124) Nephroblastoma (n=122) Rhabdomyosarcoma (n=87) Osteosarcoma (n=52) FA HT DSE BP EF RMG SNN APC ALL MCAL specific combinations of minor anomalies per tumor type

28 freq malformation in cancer % 60 Frequency Controls (n=4,412) Merks (n=1,073) Number of minor anomalies per patient Merks J, Am J Med Genet 2005;134A:132

29 freq malformation in cancer Frequency - 44 known syndromes pm 24 newly diagnosed - 34 patients syndrome suspected 1:15 children with cancer has a syndrome Merks J, Am J Med Genet 2005;134A:132 Merks J, JAMA 2008;299:61

30 freq malformation in cancer Diagnoses Cleidocranial Dysostosis

31 freq malformation in cancer Diagnoses Cleidocranial Dysostosis

32 freq malformation in cancer Diagnoses BPES

33 freq malformation in cancer Diagnoses 1994 neuroblastoma stage IV

34 freq malformation in cancer Diagnoses 2003 LEOPARD SYNDROME

35 type malformation in cancer Definitions Malformation A non-progressive congenital morphologic anomaly of a single organ or body part due to an alteration of the primary developmental program Dysplasia A morphologic anomaly arising either prenatally or postnatally from dynamic or ongoing alteration of cellular constitution, tissue organization or function within specific organ or a specific tissue type Hennekam, Am J Med Genet 2013;161A:2726

36 type malformation in cancer Cellular Growth and Development Hennekam, Am J Med Genet A:2726

37 type malformation in cancer Definitions Marfan syndrome dysplasia? FBN1 through TGFBR2

38 type malformation in cancer Definitions EEC syndrome? TP63 Van Bokhoven, personal communication 2013

39 co-localisation Localisation Site tumours vs site malformation: co-localisation? Major malformations Minor characteristics Benign tumours Malign tumours Bleeker, Eur J Med Genet 2014;57:480

40 co-localisation Localisation 2 examples microtia syndromic in 20-60% hypospadias syndromic in 10-30% sources for syndromes with tumours Winter-Baraitser Dysmorphology Database (1987) Gorlin s Syndromes of the Head and Neck (2010) PubMed at least n=100 Bleeker, Eur J Med Genet 2014;57:480

41 co-localisation Localisation Bleeker, Eur J Med Genet 2014;57:480

42 co-localisation Localisation Co-localisation of tumours with major characteristics Ab; Abdomen, Ba; Back/spine, Bl; Blood vessels, Br; Brain, Ey; Eye, Ge; Genitalia, He; Hematology/immunology, Mu; Muscle, Nec; Neck. Or; Oral region, Ske; Skeletal, Ski; Skin, Te; Teeth, Th; Thorax, Ur; Urinary system.

43 co-localisation Localisation Co-localisation of tumours with major or minor characteristics Ab; Abdomen, Ba; Back/spine, Bl; Blood vessels, Br; Brain, Ey; Eye, Ge; Genitalia, He; Hematology/immunology, Mu; Muscle, Nec; Neck. Or; Oral region, Ske; Skeletal, Ski; Skin, Te; Teeth, Th; Thorax, Ur; Urinary system.

44 co-localisation Localisation - co-localisation tumours in 60% of malformations - no difference between benign malign tumours pm reporting bias pm cave sequences: hypospadias ~ cryptorchidism ~ testis tumours

45 cancer vs development Development vs Cancer Bellacosa, Am J Med Genet 2013;161A:2788

46 cancer vs development Development vs Cancer Bellacosa, Am J Med Genet 2013;161A:2788

47 cancer vs development Development vs Cancer Cornelia de Lange s. Noonan s. Bellacosa, Am J Med Genet 2013;161A:2788

48 cancer vs development Development vs Cancer Cornelia de Lange s. Noonan s. Bloom s. Proteus s. Bellacosa, Am J Med Genet 2013;161A:2788

49 cancer vs development Development vs Cancer Cornelia de Lange s. Gorlin s. Noonan s. Bloom s. Proteus s. Bellacosa, Am J Med Genet 2013;161A:2788

50 Conclusions - 3 or more minor anomalies: high chance malformation - strong correlation cancer / malformations by - functions gene prenatal postnatal - pathway disturbances - chance for cancer in malformation depending of - entity - cause pm knowledge - chance for malformation in cancer 1:15

51 Conclusions - chance for cancer depending on type of anomaly - co-localisation cancer / malformation in 60% - change clinical manifestations from developmental disturbances to cancer cancer can be seen as a developmental disturbance / derangement of differentiation pm therapeutic consequences?

52 Complexity of relationships

53

Τhe unique constellation of tumors in AYA: Not an adult, not a child

Τhe unique constellation of tumors in AYA: Not an adult, not a child Τhe unique constellation of tumors in AYA: Not an adult, not a child Giannis Mountzios MSc, PhD Medical Oncologist 251 General Aiforce Hospital 2 nd Oncology Department, Henry Dunant Hospital Centre Athens,

More information

SOLID TUMOURS IN CHILDHOOD

SOLID TUMOURS IN CHILDHOOD SOLID TUMOURS IN CHILDHOOD Fareed Omar Paediatric Oncology Steve Biko Academic hospital Introduction 1 Introduction Lymphomas and Leukemias make up about 40% of all childhood Cancers (Systemic cancers)

More information

Radiation Oncology Study Guide

Radiation Oncology Study Guide Radiation Oncology Study Guide For the Initial CertificationQualifying (Computer-Based) Examination General and Radiation Oncology This examination is designed to assess your understanding of the entire

More information

Challenges in studying risk factors for childhood cancer

Challenges in studying risk factors for childhood cancer Challenges in studying risk factors for childhood cancer Julie A. Ross, Ph.D. Professor and Director, Division of Epidemiology & Clinical Research Department of Pediatrics, University of Minnesota & Masonic

More information

Dr.Dafalla Ahmed Babiker Jazan University

Dr.Dafalla Ahmed Babiker Jazan University Dr.Dafalla Ahmed Babiker Jazan University Brain tumors are the second commonest malignancy in children Infratentorial tumors are more common As a general rule they do not metastasize out of the CNS, but

More information

CLIC Sargent Eligibility Criteria

CLIC Sargent Eligibility Criteria 1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd

More information

Survival in Teenagers and Young. Adults with Cancer in the UK

Survival in Teenagers and Young. Adults with Cancer in the UK Survival in Teenagers and Young Adults with Cancer in the UK Survival in Teenagers and Young Adults (TYA) with Cancer in the UK A comparative report comparing TYA cancer survival with that of children

More information

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine Cancer in Children Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine 07976 608871 anant.sachdev@nhs.net Aim of this very short session! Facts and figures relating to Childrens Cancers

More information

Introduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT

Introduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT Introduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT protocols Tips Leukaemia / lymphoma: ~ 35% acute lymphoblastic

More information

Childhood Cancer. Dr Sarah Taaffe. Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session

Childhood Cancer. Dr Sarah Taaffe. Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session Childhood Cancer Dr Sarah Taaffe Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session What I plan to cover in this session Background- Why this topic.. What types of cancer

More information

Leukaemia 35% Lymphoma 14%

Leukaemia 35% Lymphoma 14% Distribution ib ti of Cancers in Children under 15 years Leukaemia 35% Lymphoma 14% Neuroblastoma 9% Other 5% Liver 1% Retinoblastoma 3% Bone and STS 15% CNS 20% Wilms' 8% 30-40% Mortality Germ Cell Tumours

More information

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group)

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) January 2013 The NCIN is a UK-wide initiative, working to drive improvements in standards of cancer care and clinical outcomes by improving

More information

Adrenal masses in infancy and childhood: A clinical and radiological overview M. Mearadji

Adrenal masses in infancy and childhood: A clinical and radiological overview M. Mearadji Adrenal masses in infancy and childhood: A clinical and radiological overview M. Mearadji International Foundation for Pediatric Imaging Aid Introduction Neoplastic adrenal masses usually originate from

More information

Epidemiology of AYA tumours. Dan Stark, MD Consultant in Medical Oncology Leeds UK

Epidemiology of AYA tumours. Dan Stark, MD Consultant in Medical Oncology Leeds UK Epidemiology of AYA tumours Dan Stark, MD Consultant in Medical Oncology Leeds UK Summary Why we should study the epidemiology of AYA tumours What is already known What is not already known and is important

More information

WHAT ARE PAEDIATRIC CANCERS

WHAT ARE PAEDIATRIC CANCERS WHAT ARE PAEDIATRIC CANCERS INTRODUCTION Childhood cancers are RARE 0.5% of all cancers in the West Overall risk that a child will develop cancer during first 15 years of life is 1 in 450 and 1 in 600

More information

Pelvic tumor in childhood Classification, imaging approach and radiological findings

Pelvic tumor in childhood Classification, imaging approach and radiological findings Pelvic tumor in childhood Classification, imaging approach and radiological findings M. Mearadji International Foundation for Pediatric Imaging Aid Rotterdam, The Netherlands Solid pelvic masses in childhood

More information

PEDIATRIC. BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a COMPANION STUDIES

PEDIATRIC. BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a COMPANION STUDIES PEDIATRIC BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in other than Average Risk Medulloblastoma/PNET Patients. https://clinicaltrials.gov/ct2/show/nct00392327?term=0332&rank=6

More information

APPENDIX 6 EPIDEMOLOGY OF CORNELIA DE LANGE SYNDROME

APPENDIX 6 EPIDEMOLOGY OF CORNELIA DE LANGE SYNDROME APPENDIX 6 EPIDEMOLOGY OF CORNELIA DE LANGE SYNDROME Table 1. List of European registries contributing to the study: years of data, total number of births, prenatal diagnosis policy, followup of cases

More information

Acknowledgements and Disclaimer

Acknowledgements and Disclaimer Infant Cancers in California, 1988 2011 Acknowledgements and Disclaimer The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of

More information

DISORDERS OF MALE GENITALS

DISORDERS OF MALE GENITALS Wit JM, Ranke MB, Kelnar CJH (eds): ESPE classification of paediatric endocrine diagnosis. 9. Testicular disorders/disorders of male genitals. Horm Res 2007;68(suppl 2):63 66 ESPE Code Diagnosis OMIM ICD10

More information

Dr Sneha Shah Tata Memorial Hospital, Mumbai.

Dr Sneha Shah Tata Memorial Hospital, Mumbai. Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas

More information

Methoden / Methods inc. ICCC-3 105

Methoden / Methods inc. ICCC-3 105 Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International

More information

Lessons from treatment of pediatric sarcomas at difficult sites. Dr. Andrea Ferrari Pediatric Oncology Unit Istituto Nazionale Tumori, Milan, Italy

Lessons from treatment of pediatric sarcomas at difficult sites. Dr. Andrea Ferrari Pediatric Oncology Unit Istituto Nazionale Tumori, Milan, Italy Lessons from treatment of pediatric sarcomas at difficult sites Dr. ndrea Ferrari Pediatric Oncology Unit stituto Nazionale Tumori, Milan, taly Disclosure slide have no potential conflicts of interest

More information

The International Classification of Diseases for Oncology (ICD-O) is

The International Classification of Diseases for Oncology (ICD-O) is 1425 COMMENTARY Classification Schemes for Tumors Diagnosed in Adolescents and Young Adults Ronald D. Barr, M.B., Ch.B., M.D. 1 3 Eric J. Holowaty, M.D., M.Sc. 4 Jillian M. Birch, B.Sc., M.Sc., Ph.D. 5

More information

Hypertrophy of liver Neonatal hypoglycemia Omphalocele Large for gestational age Other:

Hypertrophy of liver Neonatal hypoglycemia Omphalocele Large for gestational age Other: REQUEST FOR BECKWITH-WIEDEMANN SYNDROME (BWS) TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION

More information

Mohamed Agha, PhD Madeline Riehl, MHSc

Mohamed Agha, PhD Madeline Riehl, MHSc Photo by Tynan Studio Jason D. Pole, PhD Mark L. Greenberg, OC, MB, ChB, FRCPC Lillian Sung, MD, PhD, FRCPC 48 Mohamed Agha, PhD Madeline Riehl, MHSc Atlas of Childhood Cancer in Ontario (1985-2004) Chapter

More information

ANNUAL CANCER REGISTRY REPORT-2005

ANNUAL CANCER REGISTRY REPORT-2005 ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males

More information

Original Contribution. Are Children With Birth Defects at Higher Risk of Childhood Cancers?

Original Contribution. Are Children With Birth Defects at Higher Risk of Childhood Cancers? American Journal of Epidemiology ª The Author 2012. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail:

More information

Chapter 15: Non-Head and Neck Solid Tumors in Patients with Fanconi Anemia

Chapter 15: Non-Head and Neck Solid Tumors in Patients with Fanconi Anemia Chapter 15: Non-Head and Neck Solid Tumors in Patients with Fanconi Anemia Introduction Cancer is a major concern in FA patients. This chapter will describe the most common types of non-head and neck solid

More information

APPROACH TO A DYSMORPHIC INDIVIDUAL. Denise LM Goh

APPROACH TO A DYSMORPHIC INDIVIDUAL. Denise LM Goh APPROACH TO A DYSMORPHIC INDIVIDUAL Denise LM Goh Contents The dysmorphic child Incidence of congenital anomalies Suspicion for diagnosis Approach to the dysmorphic child Problem analysis history hysical

More information

CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL

CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL 1. Study title: Subsequent neoplasms among survivors of childhood cancer not previously treated with radiation 2. Working group and investigators:

More information

Pediatric cancer. Kleebsabai Sanpakit, MD. Hemato/Oncology division, Department of Pediatrics Faculty of Medicine Siriraj hospital

Pediatric cancer. Kleebsabai Sanpakit, MD. Hemato/Oncology division, Department of Pediatrics Faculty of Medicine Siriraj hospital Pediatric cancer เทคน คการให รห สโรค Siriraj Cancer ICD-O Registry ฉบ บม ออาช พ Kleebsabai Sanpakit, MD. Hemato/Oncology division, Department of Pediatrics Faculty of Medicine Siriraj hospital Different

More information

Before we are Born: Fetal Diagnosis of Congenital Heart Disease

Before we are Born: Fetal Diagnosis of Congenital Heart Disease Before we are Born: Fetal Diagnosis of Congenital Heart Disease Mohamed Sulaiman, MD Pediatric cardiologist Kidsheart: American Fetal & Children's Heart Center Dubai Healthcare City, Dubai-UAE First Pediatric

More information

Pediatric Oncology. Vlad Radulescu, MD

Pediatric Oncology. Vlad Radulescu, MD Pediatric Oncology Vlad Radulescu, MD Objectives Review the epidemiology of childhood cancer Discuss the presenting signs and symptoms, general treatment principles and overall prognosis of the most common

More information

Disturbances of female reproductive system in survivors of childhood cancer

Disturbances of female reproductive system in survivors of childhood cancer Disturbances of female reproductive system in survivors of childhood cancer Assoc. Prof. Zana Bumbuliene VU Faculty of Medicine Clinic of Obstetrics and Gynaecology 13 SEP 2014 Introduction Cancer is the

More information

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017)

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017) CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017) Leukemia AALL0932 closed after Induction Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized

More information

Pediatric Cancer in Idaho,

Pediatric Cancer in Idaho, Pediatric Cancer in Idaho, 1996-2006 Although relatively rare in comparison with cancer in older adults, cancer is the second leading cause of death in persons aged 1-14 years. The epidemiology of cancer

More information

Childhood Cancer Statistics, England Annual report 2018

Childhood Cancer Statistics, England Annual report 2018 Childhood Cancer Statistics, England Annual report 2018 Report on behalf of the Children, Teenagers and Young Adults Expert Advisory Group, National Cancer Registration and Analysis Service 1 About Public

More information

Surviving Leukemia And Hodgkin's Lymphoma: An Overview Of Effective Treatment Methods By Melinda Baxter

Surviving Leukemia And Hodgkin's Lymphoma: An Overview Of Effective Treatment Methods By Melinda Baxter Surviving Leukemia And Hodgkin's Lymphoma: An Overview Of Effective Treatment Methods By Melinda Baxter Low-grade non-hodgkin's lymphoma (NHL) is an indolent form of the disease with a Adverse effects

More information

New RT techniques: childhood cancer

New RT techniques: childhood cancer Methodology for literature review, data mining, modeling of dose response in pediatric radiation oncology Søren M Bentzen, Ph.D., D.M.Sc. Division of Biostatistics and Bioinformatics, UMGCC Shared Biostatistics

More information

Genetic counselling in PGD

Genetic counselling in PGD Genetic counselling in PGD Sérgio Castedo Serviço de Genética Faculdade de Medicina do Porto scastedo@netcabo.pt Disclosure of interests Sérgio Castedo is the CEO of GDPN, a private genetics diagnostic

More information

Clinical Study Primary Malignant Tumours of Bone Following Previous Malignancy

Clinical Study Primary Malignant Tumours of Bone Following Previous Malignancy Sarcoma Volume 2008, Article ID 418697, 4 pages doi:10.1155/2008/418697 Clinical Study Primary Malignant Tumours of Bone Following Previous Malignancy J. T. Patton, S. M. M. Sommerville, and R. J. Grimer

More information

RESEARCH COMMUNICATION. Childhood Cancer Incidence and Survival , Thailand: Study from the Thai Pediatric Oncology Group

RESEARCH COMMUNICATION. Childhood Cancer Incidence and Survival , Thailand: Study from the Thai Pediatric Oncology Group Childhood Cancer Incidence and Survival 2003-2005, Thailand RESEARCH COMMUNICATION Childhood Cancer Incidence and Survival 2003-2005, Thailand: Study from the Thai Pediatric Oncology Group Surapon Wiangnon

More information

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of )

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of ) Leukemia AALL0932 closed after Induction CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 10.10.2017) Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized

More information

Chapter 14 Beckwith Wiedemann Syndrome

Chapter 14 Beckwith Wiedemann Syndrome Chapter 14 Beckwith Wiedemann Syndrome Michael DeBaun and Jennifer Horst Beckwith-Wiedemann syndrome (BWS) (OMIM 130650) is a disease of prenatal overgrowth, congenital malformations, and predisposition

More information

Childhood cancer registration in England: 2015 to 2016

Childhood cancer registration in England: 2015 to 2016 Childhood cancer registration in England: 2015 to 2016 Report on behalf of the Children, Teenagers and Young Adults Site Specific Clinical Reference Group, National Cancer Registration and Analysis Service

More information

PITFALLS AND TRAPS IN THE DIAGNOSIS AND STAGING OF RENAL TUMOURS OF CHILDHOOD. Gordan M. Vujanić Cardiff, U.K.

PITFALLS AND TRAPS IN THE DIAGNOSIS AND STAGING OF RENAL TUMOURS OF CHILDHOOD. Gordan M. Vujanić Cardiff, U.K. PITFALLS AND TRAPS IN THE DIAGNOSIS AND STAGING OF RENAL TUMOURS OF CHILDHOOD Gordan M. Vujanić Cardiff, U.K. RENAL TUMOURS OF CHILDHOOD - CLASSIFICATION (2016) Nephroblastic tumours Mesenchymal tumours

More information

Childhood cancer survival : Dr. Behçet Uz Children s Hospital registry

Childhood cancer survival : Dr. Behçet Uz Children s Hospital registry Turkish Journal of Cancer Vol.30/ No. 2/2000 Childhood cancer survival 1990-1997: Dr. Behçet Uz Children s Hospital registry ÖZNUR DÜZOVALI 1, RAGIP ORTAÇ 2, İRFAN KARACA 3, NAZİHAT ARGON 4, YASEMİN USLU

More information

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY. Name of Test Turnaround Time Cost CPT codes

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY. Name of Test Turnaround Time Cost CPT codes Beckwith-Wiedemann: methylation and copy number 3-4 weeks $800 81401x2, 81402, 81403 Beckwith-Wiedemann: CDKN1C sequencing 3 weeks $600 81404 Beckwith-Wiedemann: prenatal diagnosis for methylation and

More information

Whole-Genome SNP Array Analysis Genomic Complexity and Clinical Relevance in Prenatal, Postnatal, and Oncology Testing

Whole-Genome SNP Array Analysis Genomic Complexity and Clinical Relevance in Prenatal, Postnatal, and Oncology Testing The Evolution of Cytogenetics Testing Whole-Genome SNP Array Analysis Genomic Complexity and Clinical Relevance in Prenatal, Postnatal, and Oncology Testing Mark Micale, Ph.D., F.A.C.M.G. Medical Director,

More information

PEDIATRIC CANCER IN IDAHO

PEDIATRIC CANCER IN IDAHO PEDIATRIC CANCER IN IDAHO 2006-2015 A Publication of the ACKNOWLEDGMENTS The Idaho Hospital Association (IHA) contracts with, and receives funding from, the Idaho Department of Health and Welfare, Division

More information

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD Immunohistochemistry in Bone and Soft Tissue Tumors Sahar Rassi Zankoul, MD Introduction Bone tumors represent a wide variety of tumors of various origins and malignant potentials. These different tumor

More information

State of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center

State of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center State of the Art Radiotherapy for Pediatric Tumors Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center Introduction Progress and success in pediatric oncology Examples of low-tech and high-tech

More information

The medical team consists of 2 Hemato-Oncologists pediatrician and 6 Hematologists pediatricians.

The medical team consists of 2 Hemato-Oncologists pediatrician and 6 Hematologists pediatricians. Dr. Robert Reid Cabral Children s Hospital Dominican Republic Brief Description of the Hematology-Oncology Service Palliative Care Pilot Program and Metronomic Therapy Dr. Robert Reid Cabral Children's

More information

6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R.

6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R. MASTERCLASS 6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY Held with the support of 11-16 June 2016 Berlin, Germany Chairs: A. Eggert, DE B. Morland, UK R. Riccardi, IT INTRODUCTION ESO and SIOP-Europe

More information

Assessing quality of life in sarkoma trials

Assessing quality of life in sarkoma trials Pan-European Clinical Trials under current EU regulations: A training course for data managers, study nurses, and junior clinical investigators London, January 24/25, 2008 Assessing quality of life in

More information

CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation

CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation Acta Radiológica Portuguesa, Vol.XVIII, nº70, pág. 41-50, Abr.-Jun., 2006 CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation Marilyn J. Siegel Mallinckrodt Institute of Radiology, Washington

More information

Second Neoplasms Working Group. CCSS Investigators Meeting June 2017

Second Neoplasms Working Group. CCSS Investigators Meeting June 2017 Second Neoplasms Working Group CCSS Investigators Meeting June 2017 Second Neoplasms Working Group Overview Ongoing review, adjudication and entry of reported neoplasms into data set Initial review of

More information

Tumors of kidney and urinary bladder

Tumors of kidney and urinary bladder Tumors of kidney and urinary bladder Overview of kidney tumors Benign and malignant Of the benign: papillary adenoma -cortical -small (0.5cm) -in 40% of population -clinically insignificant The most common

More information

FREQUENCY OF PRIMARY SOLID MALIGNANT NEOPLASMS IN DIFFERENT AGE GROUPS AS SEEN IN OUR PRACTICE

FREQUENCY OF PRIMARY SOLID MALIGNANT NEOPLASMS IN DIFFERENT AGE GROUPS AS SEEN IN OUR PRACTICE FREQUENCY OF PRIMARY SOLID MALIGNANT NEOPLASMS IN DIFFERENT AGE GROUPS AS SEEN IN OUR PRACTICE Zubair Ahmed, Najamul Sahar Azad, Fouzia Rauf, Nausheen Yaqoob, Akthar Husain, Aamir Ahsan, Rashida Ahmed,

More information

Haematopoietic stem cell transplantation (SCT)

Haematopoietic stem cell transplantation (SCT) HAEMATOPOIETIC TEM CELL TRANPLANTATION FOR CHILREN IN BELGIUM Marie-Françoise resse 1 & Yves Beguin 2 1 epartment of Paediatrics, ivision of Hemato-Oncology, UHOPL, University of Liege, Liège, Belgium;

More information

APPROACH TO ABDOMINAL MASS

APPROACH TO ABDOMINAL MASS Thomas Hong APPROACH TO ABDOMINAL MASS General Presentation An abdominal mass in a neonate, young child, or adolescent patient is something that every pediatrician needs to be wary of as these masses can

More information

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval Biochemistry of Carcinogenesis Lecture # 35 Alexander N. Koval What is Cancer? The term "cancer" refers to a group of diseases in which cells grow and spread unrestrained throughout the body. It is difficult

More information

Health Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, FOR

Health Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, FOR Health Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, 2001-2005 FOR TOWNSHIP OF TOMS RIVER, OCEAN COUNTY, NEW JERSEY AUGUST 20, 2008 U.S. DEPARTMENT OF HEALTH

More information

Tumor responses (patients responding/ patients treated)

Tumor responses (patients responding/ patients treated) Table 1. ACT clinical trial tumor responses and toxicities. a Target antigen Cancer(s) Receptor type Tumor responses (patients responding/ patients treated) Immune-mediated toxicities (patients experiencing

More information

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,

More information

Epidemiology of Childhood Cancers: Challenges and Opportunities Prof Tezer Kutluk MD PhD, FAAP President UICC, Union for International Cancer Control

Epidemiology of Childhood Cancers: Challenges and Opportunities Prof Tezer Kutluk MD PhD, FAAP President UICC, Union for International Cancer Control Epidemiology of Childhood Cancers: Challenges and Opportunities Prof Tezer Kutluk MD PhD, FAAP President UICC, Union for International Cancer Control Moscow, 02 th October 2015 Oncology Hospital Children

More information

Inside the Pediatric Cancer Genetics Clinic

Inside the Pediatric Cancer Genetics Clinic Inside the Pediatric Cancer Genetics Clinic August 23, 2014 Joyce Turner, MS, CGC Children s National Medical Center Washington, DC Pediatric Cancer Genetic Syndromes Aims over next 20-30 minutes: 1) Case

More information

First Take Home point

First Take Home point Common Presentations of Childhood Cancer First Take Home point Childhood Cancer is a rare disease New Cases of Cancer in the U.S. in 2003 Number 140000 120000 100000 80000 60000 40000 20000 0 130,000 105,000000

More information

Person-Centred Perspective Indicators in Canada:

Person-Centred Perspective Indicators in Canada: Person-Centred Perspective Indicators in Canada: A REFERENCE REPORT Adolescents and Young Adults with Cancer Adolescents and Young Adults with Cancer Section 1. Adolescent and Young Adult Cancer by the

More information

The main credit of this work would go to the team of cancer epidemiology department without them this report would have never come into light.

The main credit of this work would go to the team of cancer epidemiology department without them this report would have never come into light. Acknowledgment The main credit of this work would go to the team of cancer epidemiology department without them this report would have never come into light. Special appreciation goes to: Prof Amal Samy

More information

UK Musculoskeletal Oncology: Something for All Ages. Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky

UK Musculoskeletal Oncology: Something for All Ages. Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky UK Musculoskeletal Oncology: Something for All Ages Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky Pediatric-Type Sarcomas of Bone and Soft Tissue The incidence of sarcoma continues

More information

PEDIATRIC CANCER IN IDAHO

PEDIATRIC CANCER IN IDAHO PEDIATRIC CANCER IN IDAHO 2001-2010 May 2013 A Publication of the ACKNOWLEDGMENTS The Idaho Hospital Association (IHA) contracts with, and receives funding from, the Idaho Department of Health and Welfare,

More information

PEDIATRIC CANCER IN IDAHO

PEDIATRIC CANCER IN IDAHO PEDIATRIC CANCER IN IDAHO 1999-2008 May 2011 A Publication of the ACKNOWLEDGMENTS The Idaho Hospital Association (IHA) contracts with, and receives funding from, the Idaho Department of Health and Welfare,

More information

DUSTURBANCES OF GROWTH. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L8 Uz: Musa

DUSTURBANCES OF GROWTH. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L8 Uz: Musa DUSTURBANCES OF GROWTH MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L8 Uz: Musa Agnesia: means complete absence of an organ (Kidney). Aplasia: s defined in general as "defective development

More information

CODING TUMOUR MORPHOLOGY. Otto Visser

CODING TUMOUR MORPHOLOGY. Otto Visser CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show

More information

Update of the role of Human Papillomavirus in Head and Neck Cancer

Update of the role of Human Papillomavirus in Head and Neck Cancer Update of the role of Human Papillomavirus in Head and Neck Cancer 2013 International & 12 th National Head and Neck Tumour Conference Shanghai, 11 13 Oct 2013 Prof. Paul KS Chan Department of Microbiology

More information

28 OI November December A Medical Home for Adolescents and Young Adults with Cancer

28 OI November December A Medical Home for Adolescents and Young Adults with Cancer 28 OI November December 2013 www.accc-cancer.org A Medical Home for Adolescents and Young Adults with Cancer By Douglas S. Hawkins, MD Our team consists of more than 30 doctors specializing in cancers

More information

Dr Rodney Itaki Lecturer Division of Pathology Anatomical Pathology Discipline

Dr Rodney Itaki Lecturer Division of Pathology Anatomical Pathology Discipline Paediatric Malignancies Dr Rodney Itaki Lecturer Division of Pathology Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology First Take

More information

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE 1 CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations

More information

Index. oralmaxsurgery.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. oralmaxsurgery.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Adenomatoid odontogenic tumor, pediatric, 50 51 Ameloblastic carcinoma, pediatric, 17, 49 Ameloblastic fibro-odontoma, pediatric, 54 Ameloblastic

More information

High Incidence of Malformation Syndromes in a Series of 1,073 Children With Cancer

High Incidence of Malformation Syndromes in a Series of 1,073 Children With Cancer American Journal of Medical Genetics 134A:132 143 (2005) High Incidence of Malformation Syndromes in a Series of 1,073 Children With Cancer Johannes Hans M. Merks, 1 * Huib N. Caron, 1 and Raoul C.M. Hennekam

More information

A Cytopathological and Histopathological Correlation Study of Benign and Malignant Paediatric Age Group Tumour

A Cytopathological and Histopathological Correlation Study of Benign and Malignant Paediatric Age Group Tumour Original Research Article A Cytopathological and Histopathological Correlation Study of Benign and Malignant Paediatric Age Group Tumour Mukesh Kumar Khinchi 1*, Manish Kumar Singhal 1, Sangita Sehgal

More information

CCSS Concept Proposal Working Group: Biostatistics and Epidemiology

CCSS Concept Proposal Working Group: Biostatistics and Epidemiology Draft date: June 26, 2010 CCSS Concept Proposal Working Group: Biostatistics and Epidemiology Title: Conditional Survival in Pediatric Malignancies: A Comparison of CCSS and SEER Data Proposed Investigators:

More information

PEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP. Denise Rokitka, MD, MPH

PEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP. Denise Rokitka, MD, MPH PEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP Denise Rokitka, MD, MPH Objectives Describe incidence of childhood cancer and survival rates and causes of early mortality. Understand the late effects of cancer

More information

Report on Cancer Statistics in Alberta. Childhood Cancer

Report on Cancer Statistics in Alberta. Childhood Cancer Report on Cancer Statistics in Alberta Childhood Cancer November 2009 Surveillance - Cancer Bureau Health Promotion, Disease and Injury Prevention Report on Cancer Statistics in Alberta - 2 Purpose of

More information

Characteristics and trends in incidence of childhood cancer in Beijing, China,

Characteristics and trends in incidence of childhood cancer in Beijing, China, Original Article Characteristics and trends in incidence of childhood cancer in Beijing, China, 2000-2009 Lei Yang, Yannan Yuan, Tingting Sun, Huichao Li, Ning Wang Key Laboratory of Carcinogenesis and

More information

Reproductive function in cancer survivors

Reproductive function in cancer survivors Reproductive function in cancer survivors Professor W Hamish Wallace hamish.wallace@nhs.net Symposium 20: Endocrine consequences of childhood cancer treatment Liffey Hall 2, 0905 19 May 2015 CONFLICT OF

More information

Topics for discussion. Pediatric General Surgery. Physiology. Surgical Newborns. Neonatal Intestinal Obstruction

Topics for discussion. Pediatric General Surgery. Physiology. Surgical Newborns. Neonatal Intestinal Obstruction Topics for discussion Pediatric General Surgery Professor General & Thoracic Surgery What makes Pediatric Surgery unique? Neonatal intestinal obstruction Abdominal wall defects Inguinal hernias Appendicitis

More information

Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository ( ) for cancer in Teenagers and Young Adults

Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository ( ) for cancer in Teenagers and Young Adults Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository (2007 09) for cancer in Teenagers and Young Adults (TYA) CTYA SSCRG Data quality report on the frequency

More information

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Residents: Pediatric residents at the PL3 level Prerequisites: Successful completion or waiver

More information

3. BACKGROUND AND RATIONALE

3. BACKGROUND AND RATIONALE CHILDHOOD CANCER SURVIVOR STUDY Revised Analysis Concept Proposal 10-17 October 12, 2011 1. STUDY TITLE: Growth Hormone Exposure as a risk factor for the development of Subsequent Central Nervous System

More information

Classification of Neoplasms

Classification of Neoplasms Classification of Neoplasms ICD-10 Chapter 2, Neoplasms Codes C00-D48 Notes at beginning of Chapter 2 Classified by behaviour and site Correct use of Alphabetic index required Main terms Modifiers Table

More information

Clinical Biochemistry Department City Hospital

Clinical Biochemistry Department City Hospital Cancer Biochemistry and Tumour Markers Clinical Biochemistry Department City Hospital In this lecture Cancer basics Definition of Tumour Marker (TM) What is the perfect TM? History of TMs Examples of TMs

More information

MR Tumor Staging for Treatment Decision in Case of Wilms Tumor

MR Tumor Staging for Treatment Decision in Case of Wilms Tumor MR Tumor Staging for Treatment Decision in Case of Wilms Tumor G. Schneider, M.D., Ph.D.; P. Fries, M.D. Dept. of Diagnostic and Interventional Radiology, Saarland University Hospital, Homburg/Saar, Germany

More information

What All of Us Should Know About Cancer and Genetics

What All of Us Should Know About Cancer and Genetics What All of Us Should Know About Cancer and Genetics Beth A. Pletcher, MD, FAAP, FACMG Associate Professor of Pediatrics UMDNJ- New Jersey Medical School Disclosures I have no relevant financial relationships

More information

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Presentation outline Background and epidemiology of sarcomas Sarcoma classification Sarcoma

More information

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Evolution of Genetic Testing Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Genetic Testing Chromosomal analysis Flourescent in situ hybridization (FISH) Chromosome

More information

came from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary

came from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary Thorax 1982;37:366-370 Thoracic metastases MARY P SHEPHERD From the Thoracic Surgical Unit, Harefield Hospital, Harefield ABSTRACI One hundred and four patients are reviewed who were found to have thoracic

More information

Rhabdomyosarcoma Causes, Risk Factors, and Prevention

Rhabdomyosarcoma Causes, Risk Factors, and Prevention Rhabdomyosarcoma Causes, Risk Factors, and Prevention Risk Factors and Causes A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors and

More information